None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients were eligible for the study based on the following criteria: suspected solid pancreatic masses based on clinical work up and image modality that required cytopathological confirmation.
Exclusion criteria
Exclusion criteria: Exclusion criteria included: (a) cystic pancreatic lesions without the evidence of solid component suspected with malignant transformation; (b) cardiopulmonary instability; (c) severe coagulopathy (international normalized ratio > 1.5 or platelet count < 50,000 cells/cubic millimeter [cmm3]); (d) inability to suspend antithrombotic therapy; (e) pregnancy; (f) refusal to provide informed consent or participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the procurement rates of histologic cores that the cyto-pathologist considered to be of optimal quality for histological evaluation of the needle gauge used for the EUS-FNB procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| diagnostic performance: diagnostic accuracy, sensitivity, specificity, PPV, NPV;Technical failure;Procedure related adverse events | — |
Countries
Korea, Republic of
Contacts
Hallym University Medical Center-Dongtan